Asahi Kasei Pharma discovers, develops, manufactures, and delivers prescription drugs in the fields of orthopedics, circulatory, urology, the immune system, and the central nervous system. Pharmaceuticals from Asahi Kasei Pharma include Teribone™ for osteoporosis and Elcitonin™ Injection 20S for osteoporosis pain, the Recomodulin™ anticoagulant, the Flivas™ agent for dysuria, the Bredinin™ immunosuppressant, the Toledomin™ antidepressant, and the Eril™ Rho-kinase inhibitor, each of which has a competitive position in its respective market.

The product information contained in this website is intended for general information purposes. The names, descriptions, and labeling of approved products are of Japan origin. Product availability, names, indications, and presentations may vary from country to country.

TERIBONE™ (teriparatide acetate)

Teribone™ is a human parathyroid hormone preparation that facilitates bone formation, for the indication of osteoporosis with weekly or twice weekly subcutaneous injections.

RECLAST® (zoledronic acid)

Reclast® is a bisphosphonate agent that suppresses bone resorption, for the treatment of osteoporosis with once-a-year intravenous infusion.
Reclast® is a registered trademark of Novartis.

ELCITONIN™ (elcatonin) Injection 20S

Elcitonin™ Injection 20S is an osteoporosis therapeutic agent (calcitonin preparation) indicated for the treatment of pain associated with osteoporosis.

RECOMODULIN™ (thrombomodulin alpha)

Recomodulin™ is a thrombomodulin agent produced through genetic engineering, indicated for the treatment of disseminated intravascular coagulation (DIC) associated with malignant tumors, infectious diseases, etc.

KEVZARA® (sarilumab)

Kevzara® is a human monoclonal antibody that blocks the action of IL-6, for the treatment of rheumatoid arthritis.
Kevzara® is a registered trademark of Sanofi Biotechnology.

PLAQUENIL® (hydroxychloroquine sulfate)

Plaquenil® is an immunomodulator indicated for the treatment of cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE).
Plaquenil® is a registered trademark of Sanofi-Aventis U.S.

BREDININ™ (mizoribine)

Bredinin™ is an immunosuppressant used in suppression of immune response following renal transplantation, and to treat nephrotic syndrome, lupus nephritis, and rheumatoid arthritis.

FLIVAS™ (naftopidil)

Flivas™ is an α1 blocker indicated for the treatment of dysuria (difficulty in urination, nocturia, and incomplete emptying, etc.) accompanying benign prostatic hyperplasia.

TOLEDOMIN™ (milnacipran hydrochloride)

Toledomin™ is a type of antidepressant called SNRI (serotonin-norepinephrine reuptake inhibitor).
Toledomin™ is a registered trademark of Pierre Fabre Medicament SA.

ERIL™ (fasudil hydrochloride hydrate)

Eril™ is a Rho-kinase inhibitor used to treat cerebral vasospasm and delayed cerebral ischemic symptoms after subarachnoid hemorrhage.

FAMVIR® (famciclovir)

Famvir® is an anti-herpes virus agent indicated for the treatment of herpes zoster and herpes simplex.
Famvir® is marketed in Japan by Maruho Co., Ltd.
Famvir® is a registered trademark of Novartis Pharma AG.


Page Top